Skip to Content

Kisqali Side Effects

Generic name: ribociclib

Medically reviewed by Drugs.com. Last updated on June 14, 2020.

Note: This document contains side effect information about ribociclib. Some of the dosage forms listed on this page may not apply to the brand name Kisqali.

For the Consumer

Applies to ribociclib: oral tablet

Side effects requiring immediate medical attention

Along with its needed effects, ribociclib (the active ingredient contained in Kisqali) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking ribociclib:

More common

  • Black, tarry stools
  • bladder pain
  • bleeding gums
  • bloating or swelling of the face, arms, hands, lower legs, or feet
  • bloody or cloudy urine
  • chills
  • cough
  • difficult, burning, or painful urination
  • fever
  • frequent urge to urinate
  • lower back or side pain
  • pale skin
  • pinpoint red spots on the skin
  • sore throat
  • tightness in the chest
  • tingling of the hands or feet
  • trouble breathing
  • ulcers, sores, or white spots in the mouth
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • unusual weight gain or loss

Less common

  • Chest pain
  • confusion
  • dark urine
  • fainting
  • general feeling of discomfort or illness
  • irregular heartbeat
  • loss of appetite
  • mood or mental changes
  • muscle cramps in the hands, arms, feet, legs, or face
  • nausea
  • numbness and tingling around the mouth, fingertips, or feet
  • pain or tenderness in the upper stomach
  • pale stools
  • seizures
  • stomach cramps
  • thickening of bronchial secretions
  • tremor
  • vomiting
  • yellow eyes or skin

Incidence not known

  • Blistering, peeling, loosening of skin
  • diarrhea
  • joint or muscle pain
  • rash or itching skin
  • red irritated eyes
  • red skin lesions, often with a purple center
  • swollen glands

Side effects not requiring immediate medical attention

Some side effects of ribociclib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to ribociclib: oral tablet

General

-The most common adverse reactions (reported at a frequency 20% or more) were neutropenia, nausea, fatigue, diarrhea, leukopenia, alopecia, vomiting, constipation, headache, and back pain.

-The most common laboratory abnormalities (reported at a frequency 20% or more) were decreased leukocyte count, decreased neutrophil count, decreased hemoglobin, decreased lymphocyte count, increased ALT, increased AST, decreased platelet count, and increased creatinine.[Ref]

Hematologic

Very common (10% or more): Decreased leukocyte count (93%), decreased neutrophil count (93%), neutropenia (75%), decreased hemoglobin (57%), decrease lymphocyte count (51%), leukopenia (33%), decreased platelet count (29%), anemia (18%), lymphopenia (11%)[Ref]

Gastrointestinal

Very common (10% or more): Nausea (52%), diarrhea (35%), vomiting (29%), constipation (25%), stomatitis (12%), abdominal pain (11%)[Ref]

Hepatic

Very common (10% or more): Increased ALT (46%), increased AST (44%), abnormal liver function tests (18%), decreased appetite

Frequency not reported: Increased blood bilirubin[Ref]

Other

Very common (10% or more): Fatigue (37%), pyrexia (13%), peripheral edema (12%)

Uncommon (0.1% to 1%): On-treatment deaths, sudden death[Ref]

Dermatologic

Very common (10% or more): Alopecia (33%), rash (17%), pruritus (14%)[Ref]

Nervous system

Very common (10% or more): Headache (22%), insomnia (12%)

Common (1% to 10%): Syncope[Ref]

Metabolic

Very common (10% or more): Increased creatinine (20%), decreased appetite (19%), decreased phosphorous (13%), decreased potassium (11%)[Ref]

Musculoskeletal

Very common (10% or more): Back pain (20%)[Ref]

Respiratory

Very common (10% or more): Dyspnea (12%)

Common (1% to 10%): Epistaxis[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection (11%)[Ref]

Cardiovascular

Frequency not reported: QT interval prolongation[Ref]

Ocular

Common (1% to 10%): Lacrimation increased, dry eye[Ref]

References

1. "Product Information. Kisqali (ribociclib)." Novartis Pharmaceuticals, East Hanover, NJ.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.